We are live on ! Find out more
WST icon

West Pharmaceutical

390.30 USD
-6.39
1.61%
At close Updated Nov 20, 4:00 PM EST
Pre-market
After hours
390.30
0.00
0%
1 day
-1.61%
5 days
-6.41%
1 month
0.39%
3 months
10.33%
6 months
27.76%
Year to date
41.21%
1 year
51.41%
5 years
-10.83%
10 years
385.99%
 

About: West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Employees: 10,800

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 46.7%
Neutral 46.7%
Negative 6.7%
Positive
Seeking Alpha
1 day ago
My Top Dividend Growth Picks In Each GICS Sector (November 2026)
I present my top dividend growth picks in each GICS sector based on quality scores. The sector winners would have returned 144% over five years, versus SPY's 63%. Royal Gold is my standout value candidate. It meets all my criteria for opening a new portfolio position, including quality, safety, total return, and valuation thresholds. Valuation matters: my May picks that traded below fair value returned 16.1% on average, while those at or above fair value lost 11.1%.
My Top Dividend Growth Picks In Each GICS Sector (November 2026)
Positive
Zacks Investment Research
2 days ago
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical's growth prospects are fueled by strong HVP demand, expanding biologics exposure and regulatory upgrades, despite near-term headwinds.
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Neutral
Seeking Alpha
3 days ago
West Pharmaceutical Services, Inc. (WST) Presents at Jefferies Global Healthcare Conference 2026 Transcript
West Pharmaceutical Services, Inc. (WST) Presents at Jefferies Global Healthcare Conference 2026 Transcript
West Pharmaceutical Services, Inc. (WST) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Neutral
Seeking Alpha
3 days ago
Artisan Global Discovery Fund Q3 2026 Portfolio Activity
During the quarter, we initiated new positions in Manhattan Associates, Okta and Clean Harbors. In addition to Twilio, West Pharmaceutical and RBC Bearings, we added to Neptune Insurance, Lattice Semiconductor and Cognex during the quarter. In addition to Modine Manufacturing, we ended our investment campaigns in Monolithic Power Systems and Tradeweb Markets.
Artisan Global Discovery Fund Q3 2026 Portfolio Activity
Positive
Seeking Alpha
7 days ago
Top 50 High-Quality Dividend Growth Stocks For November 2026
I track 50 high-quality dividend growth stocks to identify favorable entry points, prioritizing long-term total return alongside a growing dividend stream. Forty stocks offer estimated future returns of at least 10%; 27 appear undervalued relative to historical free cash flow. ResMed leads with 41.60% estimated return potential; MarketAxess rose to fifth at 28.50% after a valuation upgrade and higher fair value estimate.
Top 50 High-Quality Dividend Growth Stocks For November 2026
Neutral
Seeking Alpha
8 days ago
Dividend Champion, Contender, And Challenger Highlights: Week Of November 15
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Dividend Champion, Contender, And Challenger Highlights: Week Of November 15
Positive
Seeking Alpha
14 days ago
69 Dividend Champions Ranked By Quality Scores (November 2026)
I present 69 Dividend Champions with Dividend Safety scores of 8+ and rank them using my 9F Quality Scores system. Twenty-two featured Dividend Champions are undervalued, while 21 are overvalued. Forty-nine have quality scores ≥ 7.0, indicating high quality. Top candidates by style: BRO and BMI for growth; BRO, BMI, and RGLD (below $262) for total return; CTBI for income; CAT for past performance.
69 Dividend Champions Ranked By Quality Scores (November 2026)
Positive
Zacks Investment Research
16 days ago
West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?
Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?
Neutral
PRNewsWire
17 days ago
West to Participate in Upcoming Investor Conference
EXTON, Pa., Nov. 4, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London, UK.
West to Participate in Upcoming Investor Conference
Neutral
MarketBeat
22 days ago
What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call
West Pharmaceutical Services NYSE: WST reported third-quarter results that exceeded its expectations, driven by continued demand for high-value product components, including those used in GLP-1 therapies and biologics. The company raised its full-year revenue and adjusted earnings outlook following the quarter.
What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call
Price charts implemented using Lightweight Charts™